Grand Medical

Executive Summary

Grand Medical is an Israeli med-tech distributor specializing in neurophysiology equipment, including EMG, EEG, and TMS/rTMS devices, with a focus on neurology, psychiatry, rheumatology, ENT, and sleep medicine. Founded in 2022 and based in Ramat Gan, the company has secured ISO 9001 and CE certifications, positioning itself as a reliable supplier of diagnostic and therapeutic hardware. Its portfolio features the Litebox EMG system, Neuron Spectrum EEG platforms, and NeuroMS-X magnetic stimulation units. The company serves a niche but growing market, leveraging its certifications to differentiate itself in the competitive med-tech distribution landscape. With a team of 10-50 employees and a commercial-stage business model, Grand Medical is well-placed to capture demand from Israeli specialists and potentially expand into adjacent regions. Despite its early stage and lack of disclosed funding, Grand Medical benefits from the increasing adoption of non-invasive neurostimulation and advanced diagnostics in areas such as depression, chronic pain, and sleep disorders. The company's growth trajectory hinges on expanding its product offerings, securing exclusive distribution agreements, and entering new geographies. Key risks include limited market size in Israel and reliance on third-party manufacturers. Nevertheless, its certifications and established customer base provide a solid foundation for steady growth. The company has not yet attracted significant investor attention, but its focused strategy and certifications suggest moderate upside potential.

Upcoming Catalysts (preview)

• Q3 2026Exclusive distribution deal for new neuromodulation device65% success
• Q4 2026Expansion into European markets via existing CE certification50% success
• Q2 2027FDA clearance for NeuroMS-X magnetic stimulator30% success